News

Press Releases
Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest

WINNIPEG, Manitoba – September 28, 2016 – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation”) announced that on September 28, 2016, it issued 256,600 common shares of the Corporation (“Common Shares”) in payment of $12,830 in interest owing on the Corporation’s $500,000…

> Read More

Press Releases
Kane Biotech Announces end of Joint Development Agreement and Appointment of Vice-President Sales

Kane Biotech Announces end of Joint Development Agreement and Appointment of Vice-President Sales

WINNIPEG, Manitoba – July 11, 2016 – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”) today announced that the global animal health company with which it…

> Read More

Press Releases
Kane Biotech Announces Closing of Private Placement Offering and Issuance of Common Shares in Payment of Outstanding Interest

WINNIPEG, Manitoba – June 29, 2016 – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”) today announced that the Corporation has closed its previously announced private placement offering (the “Offering”) of common shares (“Common Shares”) at a price of…

> Read More

Press Releases
Kane Biotech Announces Grant of Options

Kane Biotech Announces Grant of Options

WINNIPEG, Manitoba – June 21, 2016 – Kane Biotech Inc. (TSX-V:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms is pleased to announce that the…

> Read More

Press Releases
Kane Biotech Announces Board Members

Kane Biotech Announces Board Members

WINNIPEG, Manitoba – June 6, 2016 – Kane Biotech Inc. (TSX-V:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms is pleased to announce that at the…

> Read More

Press Releases
Kane Biotech Announces Private Placement Offering and Proposed Consolidation of Shares

WINNIPEG, Manitoba – June 3, 2016 – Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) today announced the intention of the Company to undertake a non-brokered private placement offering (the “Offering”) of up to 50,000,000 common shares (“Common Shares”)…

> Read More

Press Releases
Kane Biotech Announces Insider Participation in Rights Offering

WINNIPEG, Manitoba – May 4, 2016 – Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) is pleased to announce additional information regarding the participation of the insiders of the Company in the rights offering (the “Rights Offering”) of the…

> Read More

Press Releases
Kane Biotech Announces Rights Offering Closing

WINNIPEG, Manitoba – May 4, 2016 – Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) is pleased to announce the closing of its rights offering (the “Rights Offering”) originally announced on March 29, 2016.

Upon closing of the Rights…

> Read More